Lyndra Therapeutics News and Resources

Lyndra Therapeutics, a clinical-stage biopharmaceutical company focused on pioneering long-acting oral therapies, has announced the appointment of Adam Sayer as its new President and Chief Executive Officer. Sayer, who also joins the company’s Board of Directors, succeeds Jessica Ballinger, the